Financial Summary (All financials)
In millions, except per share items | Jan-31-10 | Jan-31-09 | Jan-31-08 | Jan-31-07 | Jan-31-06 | Jan-31-05 |
Revenues | 190.6 | 187.8 | 126.7 | 79.6 | 53.9 | 36.0 |
Revenue growth | 1.5% | 48.2% | 59.1% | 47.9% | 49.5% | |
Cost of goods sold | 64.5 | 69.6 | 50.2 | 32.1 | 22.4 | 10.5 |
Gross profit | 126.1 | 118.2 | 76.4 | 47.5 | 31.4 | 25.5 |
Gross margin | 66.1% | 63.0% | 60.3% | 59.7% | 58.3% | 70.8% |
Sales and marketing | 65.9 | 58.4 | 43.2 | 32.9 | 25.6 | 14.8 |
Research and development | 41.1 | 32.6 | 23.9 | 18.0 | 16.7 | 11.4 |
General and administrative | 15.4 | 14.6 | 9.0 | 4.8 | 3.1 | 2.5 |
EBIT | 3.7 | 12.6 | 0.4 | -8.3 | -14.0 | -3.1 |
EBIT margin | 1.9% | 6.7% | 0.3% | -10.4% | -26.1% | -8.7% |
Pre-tax income | 4.9 | 16.1 | 3.0 | -8.0 | -13.8 | -3.0 |
Income taxes | 0.7 | -15.4 | 1.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 14.1% | | 32.5% | 0.0% | 0.0% | 0.0% |
Net income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
|
Diluted EPS | $0.07 | $0.50 | ($0.03) | ($1.90) | ($2.99) | ($1.17) |
Shares outstanding (diluted) | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|